Opus Genetics Inc

IRDNASDAQ · USD
3.99USD0.00 (-2.21%)
1110

Opus Genetics Inc (IRD) Option Chain

Read more

Tracking the IRD option chain helps you see every strike and expiry on Opus Genetics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IRD options activity at a glance. Use our scanner to monitor the IRD option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IRD stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where IRD options are being actively traded, and where they are not.

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy.

2026-12-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
52.8926102.611.49—4.102.50-37.34—0.500.000.500447.11
76.901,21400.200.00—0.205.00+25.31—3.901.012.890023.10
86.94100.150.00—0.157.50+87.972.206.003.510.590013.06

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank87.70% High
  • Market cap (M$)386
  • 52 weeks high-43.56%
  • 52 weeks low114.52%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$13.94
    249.37% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-10
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.59
  • EPS growth next 5 years29.14%

As of Nov 20, 2026